Investor Presentaiton

Atos Medical is the global pioneer within Laryngectomy and has shaped the market for the past +30 years Key market and business highlights Revenue by segment and geography ~50,000 New total laryngectomies per year Laryngectomy Tracheostomy Other Organic CAGR -8% -85% Global Laryngectomy market share 1.441 1.268 1.286 30 Countries with direct presence 1.175 ▪72= 89 72 227 107 152 162 171 -50% of revenues from Direct to consumer sales ~1,100 Employees globally 1.027 1.052 1.142 897 Atos product segments Lary Heat- and Moisture Exchanger (HMES) Adhesives (Adh) Voice Prostheses (VP) Accessories PROVOK BROVCI 2018 2019 2020 20212 -80% -20% -75% -10% -15% Tracheostomy & ENT 1) 46 2) Pro-forma revenues and adjusted EBITDA calculated by Coloplast, including TRACOE medical GmbH and Kapitex Healthcare LTD (together "Tracoe"). Atos closed the Tracoe transaction on October 1st 2021. Includes impact from the Tracoe acquisition Laryngectomy Tracheostomy & Other Europe North America ROW Coloplast

View entire presentation